BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3917348)

  • 1. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.
    Bøtker HE; Toft P; Klitgaard NA; Simonsen EE
    Br Heart J; 1991 Jun; 65(6):337-41. PubMed ID: 2054244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Molajo AO; Coupe MO; Bennett DH
    Br Heart J; 1984 Oct; 52(4):392-5. PubMed ID: 6148092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.
    Maragno I; Santostasi G; Gaion RM; Trento M; Grion AM; Miraglia G; Dalla Volta S
    Am Heart J; 1988 Aug; 116(2 Pt 1):385-92. PubMed ID: 3400564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between digoxin and atenolol in chronic atrial fibrillation].
    Lanas F; Salvatici R; Castillo G; Montecinos A; Stockins B; Molina E
    Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study.
    Lang R; Klein HO; Di Segni E; Gefen J; Sareli P; Libhaber C; David D; Weiss E; Guerrero J; Kaplinsky E
    Am Heart J; 1983 May; 105(5):820-5. PubMed ID: 6846125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effects of verapamil in chronic atrial fibrillation.
    Klein HO; Pauzner H; Di Segni E; David D; Kaplinsky E
    Arch Intern Med; 1979 Jul; 139(7):747-9. PubMed ID: 454060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.
    Goldman S; Probst P; Selzer A; Cohn K
    Am J Cardiol; 1975 May; 35(5):651-5. PubMed ID: 1124719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of digoxin effect in atrial fibrillation.
    Zener JC; Anggard EE; Harrison DC; Kalman SM
    JAMA; 1973 Apr; 224(2):239-41. PubMed ID: 4739495
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.
    Yahalom J; Klein HO; Kaplinsky E
    Chest; 1977 May; 71(5):592-6. PubMed ID: 856557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.
    Roth A; Harrison E; Mitani G; Cohen J; Rahimtoola SH; Elkayam U
    Circulation; 1986 Feb; 73(2):316-24. PubMed ID: 3943166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.